Cargando…

Narrative review of urinary glycan biomarkers in prostate cancer

Prostate cancer (PC) is the second most common cancer in men worldwide. The application of the prostate-specific antigen (PSA) test has improved the diagnosis and treatment of PC. However, the PSA test has become associated with overdiagnosis and overtreatment. Therefore, there is an unmet need for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatakeyama, Shingo, Yoneyama, Tohru, Tobisawa, Yuki, Yamamoto, Hayato, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Urinary Biomarkers of Urological Malignancies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100853/ https://www.ncbi.nlm.nih.gov/pubmed/33968674 http://dx.doi.org/10.21037/tau-20-964

Ejemplares similares

Urinary biomarkers of urological malignancies
por: Fujita, Kazutoshi
Publicado: (2021)

Extracellular vesicles in prostate cancer: a narrative review
por: Hatano, Koji, et al.
Publicado: (2021)

A narrative review of urinary phospholipids: from biochemical aspect towards clinical application
por: Li, Xin, et al.
Publicado: (2021)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Recent progress and perspectives on prostate cancer biomarkers
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Urinary extracellular vesicles: a rising star in bladder cancer management
por: Urabe, Fumihiko, et al.
Publicado: (2021)

UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives
por: Nagai, Takashi, et al.
Publicado: (2021)

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Kodama, Hirotake, et al.
Publicado: (2021)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer
por: Hagiwara, Kazuhisa, et al.
Publicado: (2017)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
por: Narita, Takuma, et al.
Publicado: (2017)

Testicular Metastasis of Prostate Cancer: A Case Report
por: Kusaka, Ayumu, et al.
Publicado: (2014)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation
por: Anan, Go, et al.
Publicado: (2019)

Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
por: Hatakeyama, Shingo, et al.
Publicado: (2013)

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2022)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Fujita, Naoki, et al.
Publicado: (2023)

I‐branching N‐acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
por: Mikami, Jotaro, et al.
Publicado: (2016)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2023)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Fujita, Naoki, et al.
Publicado: (2023)

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis
por: Ishikawa, Tomokazu, et al.
Publicado: (2017)

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
por: OKAMOTO, TEPPEI, et al.
Publicado: (2013)

Mixed urinary incontinence: Are there effective treatments?
por: Game, Xavier, et al.
Publicado: (2022)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Momota, Masaki, et al.
Publicado: (2018)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
por: Yoneyama, Tohru, et al.
Publicado: (2021)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

Urethral failure is not the predominant cause of female stress urinary incontinence
por: Bergström, Bo S.
Publicado: (2022)

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma
por: Horiguchi, Hirotaka, et al.
Publicado: (2018)

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
por: Kojima, Yuta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_12pjasc8btlfvi5agnm7k0r37d